Portrazza (necitumumab)

**Product type:** Human Prescription Drug

**Active ingredient:** NECITUMUMAB

**Strength:** 16 mg/mL

**Dosage form:** Solution

**Route:** Intravenous

**Labeler:** Eli Lilly and Company

**Marketing category:** BLA (BLA125547)

**Pharmacologic class:** Epidermal Growth Factor Receptor Antagonist [EPC], HER1 Antagonists [MoA]